GEN Exclusives

More »

GEN News Highlights

More »
Aug 10, 2012

Biothreat Detection in the Palm of Your Hand

  • Luminex won a potentially $11.6 million contract from the U.S. Department of Defense’s Defense Threat Reduction Agency to develop a prototype portable diagnostic system capable of use in the field for rapidly detecting infection by biothreat agents and biomarkers indicative of systemic disease. The hand-held system will be able to detect both protein and nucleic acid markers to aid diagnosis of systemic inflammatory response syndrome (SIRS), which can develop as a result of blood infections in conventional combat and biowarfare.

    “The flexibility and scalability of our multiplexing technology allow for the measurement of RNA, DNA, and proteins with the same system, aiding rapid and accurate diagnosis of these severe conditions,” remarks Amy Altman, Ph.D., vp Luminex Biodefense. “Development of a field-deployable device using our technology has the potential to provide significant advancement in biothreat detection.” 


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »